Noninvasive markers of endometriosis and their dynamics during hormone therapy
article
OA: bronze
CC0
⤵ 2 in-corpus citations
AI-generated summary
This study identified noninvasive biomarkers for endometriosis and tracked their changes over time during hormone therapy.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (14)
- Angiogenic Factors in Endometriosis via openalex
- Apoptosis and endometriosis via openalex
- A systematic review of the accuracy of ultrasound in the diagnosis of endometriosis via openalex
- Elevated serum levels of endometrial secretory protein PP14 in patients with advanced endometriosis via openalex
- Endometrial-Peritoneal Interactions during Endometriotic Lesion Establishment via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis via openalex
- Evaluation of endometrial biomarkers for semi-invasive diagnosis of endometriosis via openalex
- Serum CA-125 in the diagnosis of endometriosis via openalex
- Serum levels of VEGF and TNF-α and their association with C-reactive protein in patients with endometriosis via openalex
- The Role of Cytokines in Endometriosis* via openalex
- W2117842006 via openalex
- W1994088961 via openalex
- W2135721067 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK